Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.org..
The fixed dose combination of sitagliptin 50 mg and metformin 850 mg (Janumet ®), is indicated for the treatment of type 2 diabetes mellitus in addition to diet and exercise to improve glycemic control in patients treated with metformin alone.
METHODS: We report a 69-year-old man with type 2 diabetes that developed sudden loss of eyebrows and eyelashes about 4 months after the beginning of Janumet®. Clinical and laboratory findings excluded the presence of systemic or skin diseases able to induce these manifestations, while the Naranjo probability scale documented a possible association between the drug and the adverse drug reaction.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Current drug safety - 12(2017), 1 vom: 28., Seite 10-12 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Succurro, Elena [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 22.05.2018 Date Revised 22.05.2018 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.2174/1574886311666161014125536 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM265457408 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM265457408 | ||
| 003 | DE-627 | ||
| 005 | 20231224212324.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1574886311666161014125536 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0884.xml |
| 035 | |a (DE-627)NLM265457408 | ||
| 035 | |a (NLM)27758711 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Succurro, Elena |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Loss of Eyebrows and Eyelashes During Concomitant Treatment with Sitagliptin and Metformin |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.05.2018 | ||
| 500 | |a Date Revised 22.05.2018 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.org. | ||
| 520 | |a The fixed dose combination of sitagliptin 50 mg and metformin 850 mg (Janumet ®), is indicated for the treatment of type 2 diabetes mellitus in addition to diet and exercise to improve glycemic control in patients treated with metformin alone | ||
| 520 | |a METHODS: We report a 69-year-old man with type 2 diabetes that developed sudden loss of eyebrows and eyelashes about 4 months after the beginning of Janumet®. Clinical and laboratory findings excluded the presence of systemic or skin diseases able to induce these manifestations, while the Naranjo probability scale documented a possible association between the drug and the adverse drug reaction | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Adverse drug reaction | |
| 650 | 4 | |a metformin | |
| 650 | 4 | |a sitagliptin | |
| 650 | 4 | |a type 2 diabetes mellitus | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 650 | 7 | |a Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination |2 NLM | |
| 650 | 7 | |a Metformin |2 NLM | |
| 650 | 7 | |a 9100L32L2N |2 NLM | |
| 650 | 7 | |a Sitagliptin Phosphate |2 NLM | |
| 650 | 7 | |a TS63EW8X6F |2 NLM | |
| 700 | 1 | |a Palleria, Caterina |e verfasserin |4 aut | |
| 700 | 1 | |a Ruffo, Mariafrancesca |e verfasserin |4 aut | |
| 700 | 1 | |a Serra, Raffaele |e verfasserin |4 aut | |
| 700 | 1 | |a Arturi, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Gallelli, Luca |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current drug safety |d 2006 |g 12(2017), 1 vom: 28., Seite 10-12 |w (DE-627)NLM181475790 |x 2212-3911 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2017 |g number:1 |g day:28 |g pages:10-12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1574886311666161014125536 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2017 |e 1 |b 28 |h 10-12 | ||